Skip to content
lsd.com

Indication

Binge-Eating Disorder

2 registered trials testing Psilocybin, MDMA for this indication, none currently recruiting.

Sponsors register this under 2 different names, all collected here: Binge Eating Disorder · Binge-Eating Disorder

2
Registered trials
0
Recruiting
0
In Phase 3

Substances tested

Being studied with

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Binge-Eating Disorder trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 2 trials for Binge-Eating Disorder

TrialStatusPhaseSubstanceSites
Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating DisorderNCT05035927 · TRYP TherapeuticsCompletedPhase 2psilocybin1
A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating DisordersNCT04454684 · Resilient PharmaceuticalsWithdrawnPhase 2mdma—

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.